# The Safety and The Efficacy Evaluation of ET-STEM in Patients With Frontotemporal Dementia

> **NCT05315661** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 12 (estimated)

## Conditions studied

- Frontotemporal Dementia

## Interventions

- **DRUG:** ET-STEM

## Key facts

- **NCT ID:** NCT05315661
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-07-06
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05315661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05315661, "The Safety and The Efficacy Evaluation of ET-STEM in Patients With Frontotemporal Dementia". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05315661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*